- Home
- NAMS vs KRC Comparison
NAMS vs KRC Comparison
Compare NAMS & KRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAMS | KRC |
|---|---|---|
| Founded | 2019 | 1947 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.5B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | NAMS | KRC |
|---|---|---|
| Price | $30.14 | $28.82 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 13 |
| Target Price | ★ $46.75 | $38.42 |
| AVG Volume (30 Days) | 865.3K | ★ 1.9M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 7.66% |
| EPS Growth | N/A | ★ 31.07 |
| EPS | N/A | ★ 2.32 |
| Revenue | N/A | ★ $1,112,667,000.00 |
| Revenue This Year | $25.64 | N/A |
| Revenue Next Year | $530.85 | $1.38 |
| P/E Ratio | ★ N/A | $12.18 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.06 | $27.07 |
| 52 Week High | $42.00 | $45.03 |
Technical Indicators
Market Signals| Indicator | NAMS | KRC |
|---|---|---|
| Relative Strength Index (RSI) | 44.69 | 38.74 |
| Support Level | $29.73 | $27.89 |
| Resistance Level | $31.72 | $43.30 |
| Average True Range (ATR) | 1.62 | 0.97 |
| MACD | -0.07 | 0.12 |
| Stochastic Oscillator | 50.55 | 26.10 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About KRC Kilroy Realty Corporation
Kilroy Realty is a premier owner and landlord of approximately 16.3 million square feet of office space across Los Angeles, San Diego, the San Francisco Bay Area, Austin, Texas, and greater Seattle. The company operates as a real estate investment trust.